Brentuximab vedotin: a CD30-directed antibody-cytotoxic drug conjugate. [electronic resource]
Producer: 20131017Description: 93-104 p. digitalISSN:- 1875-9114
- Animals
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Brentuximab Vedotin
- Clinical Trials as Topic -- methods
- Cytotoxins -- therapeutic use
- Humans
- Immunoconjugates -- therapeutic use
- Immunotoxins -- therapeutic use
- Ki-1 Antigen -- antagonists & inhibitors
- Molecular Targeted Therapy -- methods
No physical items for this record
Publication Type: Case Reports; Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.